glp 1 drugs canada WHO backs GLP-1 meds to treat obesity, but many Islanders can't access them GLP-1 drugs becoming Canada's $3.4

A split-GFP tool reveals differences in the sub-mitochondrial distribution of wt and mutant alpha-synuclein

Aliment Pharmacol Ther 2013;38:584-595

Dhomen N, Reis-Filho JS, da Rocha Dias S, Hayward R, Savage K, Delmas V et al

10.1098/rstb.2016.0526 149 ShimB.CiryamP.TosunC.SerraR.TsymbalyukN.KeledjianK.et al (2025)

MT2 also crosses the blood-brain barrier, producing centrally mediated effects (appetite suppression, libido modulation) that MT1 does not

A post hoc analysis of a phase III trial found that administering the drug twice a week was linked to a significantly higher rate of severe BIPN compared to once-weekly dosing (28% vs